In a revelation that has sent shockwaves through the entertainment world, television mogul and host extraordinaire Andy Cohen has openly discussed his experimentation with the type 2 diabetes medication, Ozempic, for weight management.
The 55-year-old Bravo executive made the startling admission during a no-holds-barred interview on his own radio show, Radio Andy, confirming long-standing rumours about his changing physique.
The Micro-Dosing Revelation
Cohen didn't just admit to using the drug; he provided a detailed account of his method. He described a strategy of 'micro-dosing,' taking significantly smaller amounts of the drug than typically prescribed for diabetic patients. This method, he suggested, allowed him to reap the appetite-suppressing benefits while potentially mitigating some of the more severe side effects.
'I wasn't taking the prescribed amount,' Cohen clarified, pulling back the curtain on a practice that has become something of an open secret in Hollywood circles.
A Candid Conversation with Anderson Cooper
The confession unfolded in a conversation with fellow news anchor and friend Anderson Cooper. What began as a discussion about the broader trend of celebrities using semaglutide-based drugs quickly turned personal.
When Cooper directly asked if he had partaken, Cohen responded with a surprising and unequivocal 'Yes.' His honesty cut through the usual veil of secrecy that surrounds celebrity weight loss, providing a rare glimpse into the pressures and methods of staying camera-ready.
Navigating the Side Effects
Cohen's journey wasn't without its challenges. He spoke candidly about the 'debilitating' nausea that often accompanies the use of such drugs, a common side effect that has plagued many users. His experience highlights the extreme lengths to which some are willing to go in pursuit of a certain aesthetic, enduring significant physical discomfort for results.
This frank discussion serves as a public service announcement of sorts, laying bare the very real and unpleasant consequences that can come with these pharmaceutical shortcuts.
Fueling the Fire of a National Debate
Cohen's high-profile admission throws a massive spotlight on the ongoing ethical debate surrounding the off-label use of diabetes medications. As celebrities and influencers continue to popularise these drugs for cosmetic weight loss, a critical shortage has emerged, leaving diabetic patients who rely on them for managing their blood sugar struggling to access their essential medication.
By coming forward, Cohen has inadvertently become a central figure in a complex conversation about medical ethics, privilege, and the powerful influence of celebrity culture on public health trends.
